Quanquan Gu launches Geodesic Intelligence to build AGI for drug discovery
DeryaTR_ · x · 2026-09-10
UCLA professor Quanquan Gu announced Geodesic Intelligence, an AI-native protein therapeutics startup aiming to build AGI for drug discovery — the "shortest path from biology to medicines."
- Combines frontier AI, biological foundation models, and experimental science in a full stack
- Launching today: NovaDDE and NovaAtom-Lite-Preview
The company says this is just the beginning.
Related event: UCLA's Quanquan Gu founds Geodesic to build AGI for drug discovery(4 posts)→
More from Companies & People
- AI safety nonprofits pay AI-lab salaries; TruthfulAI hiring round soon — OwainEvans_UK · 2026-09-10
- Polymarket puts 55% odds on a touchscreen MacBook as Apple faces a photoshop scandal — Polymarket · 2026-09-10
- Investor: falling behind on agent product cycles may be impossible to recover from — matt_slotnick · 2026-09-10
- AI agents are building a new infra layer that leaves existing enterprise systems behind — matt_slotnick · 2026-09-10
- If SORs don't adapt to agents, a new platform layer will be built on top of them — matt_slotnick · 2026-09-10
- Sam Altman welcomes Paul back to OpenAI, citing his AI safety contributions — andrew_n_carr · 2026-09-10